[go: up one dir, main page]

WO2009063504A3 - Novel crystal modification of epinastine or salts thereof and process for preparation thereof - Google Patents

Novel crystal modification of epinastine or salts thereof and process for preparation thereof Download PDF

Info

Publication number
WO2009063504A3
WO2009063504A3 PCT/IN2008/000612 IN2008000612W WO2009063504A3 WO 2009063504 A3 WO2009063504 A3 WO 2009063504A3 IN 2008000612 W IN2008000612 W IN 2008000612W WO 2009063504 A3 WO2009063504 A3 WO 2009063504A3
Authority
WO
WIPO (PCT)
Prior art keywords
salts
preparation
epinastine
crystal modification
novel crystal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2008/000612
Other languages
French (fr)
Other versions
WO2009063504A2 (en
Inventor
Dhananjay Govind Sathe
Kamlesh Digambar Sawant
Narayana Rao Mantripragada
Rajesh Ganpat Bhopalkar
Hrishikesh Gurunath Saple
Tushar Anil Naik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
USV Pvt Ltd
Original Assignee
USV Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by USV Pvt Ltd filed Critical USV Pvt Ltd
Publication of WO2009063504A2 publication Critical patent/WO2009063504A2/en
Publication of WO2009063504A3 publication Critical patent/WO2009063504A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides novel crystalline forms of 3-amino-9,13b-dihydro-lH- dibenzo[c,fjimidazo[l,5-a] azepine or salts thereof and process for preparation thereof. Formula (I).
PCT/IN2008/000612 2007-09-24 2008-09-24 Novel crystal modification of epinastine or salts thereof and process for preparation thereof Ceased WO2009063504A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1872/MUM/2007 2007-09-24
IN1872MU2007 2007-09-24

Publications (2)

Publication Number Publication Date
WO2009063504A2 WO2009063504A2 (en) 2009-05-22
WO2009063504A3 true WO2009063504A3 (en) 2009-12-03

Family

ID=40551912

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2008/000612 Ceased WO2009063504A2 (en) 2007-09-24 2008-09-24 Novel crystal modification of epinastine or salts thereof and process for preparation thereof

Country Status (1)

Country Link
WO (1) WO2009063504A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104098575B (en) * 2013-04-15 2016-06-01 四川科瑞德凯华制药有限公司 Brilliant type of a kind of Epinastine Hydrochloride and its production and use
CN105153169B (en) * 2014-11-27 2018-11-30 兆科药业（广州）有限公司 A kind of synthetic method of epinastine hydrochloride
CN104974164B (en) * 2015-06-26 2017-06-27 大连理工大学 A kind of preparation method of 6-aminomethyl-6,11-dihydro-5H-dibenzo[b,e]azepine
CN115448927A (en) * 2022-10-20 2022-12-09 重庆瑞泊莱医药科技有限公司 Epinastine hydrobromide crystal form II and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0035749A1 (en) * 1980-03-08 1981-09-16 C.H. Boehringer Sohn Heterocyclic compounds, their preparation and pharmaceutical compositions containing them

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0035749A1 (en) * 1980-03-08 1981-09-16 C.H. Boehringer Sohn Heterocyclic compounds, their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
WO2009063504A2 (en) 2009-05-22

Similar Documents

Publication Publication Date Title
WO2006127933A8 (en) Processes for preparing cinacalcet hydrochloride crystal form i
WO2008066935A3 (en) Crystalline forms of tigecycline and processes for preparation thereof
EP2460797A3 (en) Process for preparation of ivabradine hydrochloride
MX340490B (en) Pyrazolo [1, 5a] pyrimidine and thieno [3, 2b] pyrimidine derivatives as irak4 modulators.
WO2008021342A3 (en) Amorphous and crystalline forms of 9-hydroxy-risperidone ( paliperidone )
WO2009036281A3 (en) Bortezomib and process for producing same
ZA200804488B (en) Pyrimidine derivatives for the treatment of abnormal cell growth
WO2007023111A3 (en) P38 map kinase inhibitors and methods for using the same
WO2008002683A3 (en) Polymorphous forms of carvedilol phosphate
WO2010014666A3 (en) Processes and intermediates for making sweet taste enhancers
WO2006024024A3 (en) Solid and crystalline ibandronate sodium and processes for preparation thereof
WO2008035066A3 (en) Processes for the preparation of ciclesonide and its crystal form
WO2008083130A3 (en) Amorphous and crystalline form a of carvedilol phosphate
WO2008053334A3 (en) An improved process for preparing rosuvastatin calcium
WO2007098273A3 (en) Novel crystalline forms of armodafinil and preparation thereof
ZA200905832B (en) Crystalline forms of an 8-azabicyclo [3.2.1] octane compound
WO2009002538A3 (en) Amorphous erlotinib, processes for the preparation thereof, and processes to prepare additional forms of erlotinib
WO2007104485A3 (en) Substituted imidazo[2,1-b]thiazole compounds and their use for producing drugs
WO2007010555A3 (en) Novel crystalline forms of moxifloxacin hydrochloride and process for preparation thereof
WO2009063504A3 (en) Novel crystal modification of epinastine or salts thereof and process for preparation thereof
WO2010027848A3 (en) Forms of lapatinib compounds and processes for the preparation thereof
WO2008140646A3 (en) Process for the synthesis of cmhtp and intermediates thereof
WO2006027370A8 (en) PREPARATION OF 9-HYDROXY-3- (2-HYDROXYETHYL) -2-METHYL-4H-PYRID0[1, 2-a] PYRIMIDIN-4-ONE AND CRYSTALS THEREOF
WO2006117763A3 (en) A process for the preparation of doripenem
WO2008041176A3 (en) Process for the preparation of form i and form ii of ritonavir

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08849519

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08849519

Country of ref document: EP

Kind code of ref document: A2